OrthoPediatrics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.05	2.06	1.96	1.97	1.47	1.37
Short-Term Investments	36.62	41.3	25.01	49.25	109.3	45.9
Cash & Short-Term Investments	38.67	43.36	26.97	51.22	110.77	47.27
Cash Growth	41.52%	60.77%	-47.35%	-53.76%	134.35%	-16.36%
Accounts Receivable	54.43	53.84	42.36	34.62	24.8	17.94
Total Trade Receivables	54.43	53.84	42.36	34.62	24.8	17.94
Inventory	134.02	133.79	117.01	105.85	78.19	57.57
Other Current Assets	6.55	5.88	7.02	3.75	3.97	3.23
Total Current Assets	245.87	256.42	237.17	226.5	226.72	133.65
Net Property, Plant & Equipment	48.55	49.56	50.6	41.05	34.29	28.52
Other Intangible Assets	76.72	77.71	81.18	84.56	79.9	69.76
Goodwill	115.17	109.27	93.84	83.7	86.82	72.35
Other Long-Term Assets	15.88	15.68	10.42	2.94	-	-
Total Assets	502.19	508.63	473.21	438.75	427.73	304.27
Accounts Payable	19.7	18.79	8.91	12.65	11.15	9.33
Accrued Expenses	12.77	13.69	13.89	11.33	6.74	5.35
Current Portion of Long-Term Debt	0.17	0.17	0.16	0.15	0.14	0.14
Other Current Liabilities	14.54	13.55	11.01	17.54	12.83	14.9
Total Current Liabilities	47.18	46.2	33.96	41.67	30.87	29.72
Long-Term Debt	100.39	99.82	72.96	9.91	0.76	0.91
Other Long-Term Liabilities	15.91	16.02	11.73	10.15	17.45	48.28
Total Long-Term Liabilities	116.3	115.84	84.68	20.05	18.21	49.19
Total Liabilities	163.48	162.03	118.64	61.72	49.08	78.91
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	626.01	622.33	600.9	580.29	560.81	394.9
Accumulated Other Comprehensive Income	-1.4	-0.52	-10.77	-5.53	-5.4	8.49
Retained Earnings	-285.9	-275.21	-235.56	-197.74	-176.77	-178.03
Shareholders' Equity	338.71	346.6	354.57	377.03	378.65	225.37
Total Liabilities & Equity	502.19	508.63	473.21	438.75	427.73	304.27
Total Debt	100.56	99.99	73.12	10.06	0.91	1.04
Net Cash (Debt)	-61.89	-56.63	-46.15	41.16	109.86	46.22
Net Cash Growth	-	-	-	-62.53%	137.68%	-16.48%
Net Cash Per Share	-2.63	-2.41	-2.00	1.81	5.25	2.40
Book Value	338.71	346.6	354.57	377.03	378.65	225.37
Book Value Per Share	14.37	14.77	15.36	16.63	18.08	11.70
Tangible Book Value	146.82	159.62	179.54	208.76	211.93	83.26
Tangible Book Value Per Share	6.23	6.80	7.78	9.21	10.12	4.32

SEC Filings: 10-K · 10-Q